Katarina Niward

1.2k total citations · 1 hit paper
17 papers, 231 citations indexed

About

Katarina Niward is a scholar working on Infectious Diseases, Epidemiology and Pharmacology. According to data from OpenAlex, Katarina Niward has authored 17 papers receiving a total of 231 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Infectious Diseases, 7 papers in Epidemiology and 5 papers in Pharmacology. Recurrent topics in Katarina Niward's work include Tuberculosis Research and Epidemiology (10 papers), Intensive Care Unit Cognitive Disorders (5 papers) and Antibiotics Pharmacokinetics and Efficacy (5 papers). Katarina Niward is often cited by papers focused on Tuberculosis Research and Epidemiology (10 papers), Intensive Care Unit Cognitive Disorders (5 papers) and Antibiotics Pharmacokinetics and Efficacy (5 papers). Katarina Niward collaborates with scholars based in Sweden, Australia and China. Katarina Niward's co-authors include Anestis Divanoglou, Åse Östholm Balkhed, Richard Levi, Carl Wahlgren, Sören Berg, Judith Bruchfeld, Thomas Schön, Jakob Paues, Lina Davies Forsman and Ulrika Birberg Thornberg and has published in prestigious journals such as Antimicrobial Agents and Chemotherapy, Journal of Antimicrobial Chemotherapy and Journal of Internal Medicine.

In The Last Decade

Katarina Niward

17 papers receiving 228 citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Two-year follow-up of patients with post-COVID-19 condition in Sweden: a prospective cohort study

2023 63 citations Carl Wahlgren, Anestis Divanoglou et al. The Lancet Regional Health - Europe profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Katarina Niward Sweden	7	124	94	63	59	40	17	231
Cynthia Putri Indonesia	7	167 1.3×	140 1.5×	82 1.3×	45 0.8×	19 0.5×	14	318
Alexandra Fox United States	8	86 0.7×	40 0.4×	28 0.4×	32 0.5×	15 0.4×	10	201
Caroline Barkholt Kamp Denmark	8	47 0.4×	68 0.7×	35 0.6×	11 0.2×	15 0.4×	32	214
Wagner Rodrigues de Assis Soares Brazil	4	188 1.5×	134 1.4×	55 0.9×	33 0.6×	7 0.2×	6	287
Naiane Oliveira Santos Brazil	3	188 1.5×	134 1.4×	55 0.9×	33 0.6×	6 0.1×	7	274
S. Pescariu Romania	8	94 0.8×	94 1.0×	34 0.5×	22 0.4×	19 0.5×	29	227
Yolanda Ruíz Spain	6	90 0.7×	54 0.6×	39 0.6×	21 0.4×	14 0.3×	16	155
Luigi Mirarchi Italy	8	86 0.7×	36 0.4×	42 0.7×	27 0.5×	48 1.2×	14	259
Yusuf Emre Özdemir Türkiye	7	120 1.0×	89 0.9×	96 1.5×	20 0.3×	11 0.3×	29	241
Naruhiko Sunada Japan	11	242 2.0×	86 0.9×	66 1.0×	54 0.9×	7 0.2×	25	291

Countries citing papers authored by Katarina Niward

Since Specialization

Citations

This map shows the geographic impact of Katarina Niward's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Katarina Niward with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Katarina Niward more than expected).

Fields of papers citing papers by Katarina Niward

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Katarina Niward. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Katarina Niward. The network helps show where Katarina Niward may publish in the future.

Co-authorship network of co-authors of Katarina Niward

This figure shows the co-authorship network connecting the top 25 collaborators of Katarina Niward. A scholar is included among the top collaborators of Katarina Niward based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Katarina Niward. Katarina Niward is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

Wang, Sainan, Lina Davies Forsman, Haoyue Zhang, et al.. (2024). Second-line antituberculosis drug exposure thresholds predictive of adverse events in multidrug-resistant tuberculosis treatment. International Journal of Infectious Diseases. 140. 62–69. 2 indexed citations

Möller, Marika C., Kristian Borg, Christer Janson, et al.. (2023). Cognitive dysfunction in post‐COVID‐19 condition: Mechanisms, management, and rehabilitation. Journal of Internal Medicine. 294(5). 563–581. 20 indexed citations

Wahlgren, Carl, Anestis Divanoglou, Åse Östholm Balkhed, et al.. (2023). Two-year follow-up of patients with post-COVID-19 condition in Sweden: a prospective cohort study. The Lancet Regional Health - Europe. 28. 100595–100595. 63 indexed citations breakdown →

Zhang, Haoyue, Lina Davies Forsman, Jakob Paues, et al.. (2023). Population pharmacokinetics and dose evaluations of linezolid in the treatment of multidrug-resistant tuberculosis. Frontiers in Pharmacology. 13. 1032674–1032674. 6 indexed citations

Zhu, Limei, Lina Davies Forsman, Jakob Paues, et al.. (2023). Population Pharmacokinetics and Dose Evaluation of Cycloserine among Patients with Multidrug-Resistant Tuberculosis under Standardized Treatment Regimens. Antimicrobial Agents and Chemotherapy. 67(5). e0170022–e0170022. 5 indexed citations

Forsman, Lina Davies, Jakob Paues, Jim Werngren, et al.. (2023). Population pharmacokinetics and model-based dosing evaluation of bedaquiline in multidrug-resistant tuberculosis patients. Frontiers in Pharmacology. 14. 1022090–1022090. 5 indexed citations

Taxbro, Knut, Louise Elander, Håkan Hanberger, et al.. (2023). Risk factors for ventilator‐associated lower respiratory tract infection in COVID‐19, a retrospective multicenter cohort study in Sweden. Acta Anaesthesiologica Scandinavica. 68(2). 226–235. 2 indexed citations

Fredrikson, Mats, Björn Carlsson, Ulrika S. H. Simonsson, et al.. (2022). Safety and pharmacokinetics-pharmacodynamics of a shorter tuberculosis treatment with high-dose pyrazinamide and rifampicin: a study protocol of a phase II clinical trial (HighShort-RP). BMJ Open. 12(3). e054788–e054788. 3 indexed citations

Berg, Sören, et al.. (2022). Improved 60‐day survival but impaired general health in Swedish ICU‐COVID patients: An ambidirectional population‐based study. Acta Anaesthesiologica Scandinavica. 66(5). 569–579. 3 indexed citations

10.

Wahlgren, Carl, Anestis Divanoglou, Emma Nilsson, et al.. (2021). Rehabilitation Needs Following COVID-19: Five-Month Post-Discharge Clinical Follow-Up of Individuals With Concerning Self-Reported Symptoms. SSRN Electronic Journal. 6 indexed citations

11.

Wahlgren, Carl, Anestis Divanoglou, Emma Nilsson, et al.. (2021). Rehabilitation needs following COVID-19: Five-month post-discharge clinical follow-up of individuals with concerning self-reported symptoms. EClinicalMedicine. 43. 101219–101219. 42 indexed citations

12.

Zheng, Xubin, Yi Hu, Rongrong Zheng, et al.. (2020). Development and validation of a simple LC-MS/MS method for simultaneous determination of moxifloxacin, levofloxacin, prothionamide, pyrazinamide and ethambutol in human plasma. Journal of Chromatography B. 1158. 122397–122397. 23 indexed citations

13.

Schulman, Howard, Katarina Niward, Ebba Abate, et al.. (2019). Sedimentation rate and suPAR in relation to disease activity and mortality in patients with tuberculosis. The International Journal of Tuberculosis and Lung Disease. 23(11). 1155–1161. 5 indexed citations

14.

Svensson, Robin J., Katarina Niward, Lina Davies Forsman, et al.. (2019). Individualised dosing algorithm and personalised treatment of high‐dose rifampicin for tuberculosis. British Journal of Clinical Pharmacology. 85(10). 2341–2350. 16 indexed citations

15.

Niward, Katarina, Lina Davies Forsman, Judith Bruchfeld, et al.. (2018). Plasma Levels of Rifampin Correlate with the Tuberculosis Drug Activity Assay. Antimicrobial Agents and Chemotherapy. 62(5). 4 indexed citations

16.

Niward, Katarina, Lina Davies Forsman, Judith Bruchfeld, et al.. (2018). Distribution of plasma concentrations of first-line anti-TB drugs and individual MICs: a prospective cohort study in a low endemic setting. Journal of Antimicrobial Chemotherapy. 73(10). 2838–2845. 14 indexed citations

17.

Niward, Katarina, Kristian Ängeby, Erja Chryssanthou, et al.. (2015). Susceptibility testing breakpoints forMycobacterium tuberculosiscategorize isolates with resistance mutations ingyrAas susceptible to fluoroquinolones: implications for MDR-TB treatment and the definition of XDR-TB. Journal of Antimicrobial Chemotherapy. 71(2). 333–338. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact